Core Insights - Scientific Industries, Inc. reported a 15% year-over-year increase in sales from its Torbal Division, contributing to a 52.2% rise in net revenues for Q3 2025 compared to Q3 2024 [1][6][8] - The company launched its first AI-powered feature for the VIVID WORKSTATION, enhancing pharmacy automation and compliance [1][4] - The financial results for the nine months ended September 30, 2025, showed a slight decline in total revenues, primarily due to decreased revenues from Bioprocessing Systems Operations [8][12] Business Highlights - The introduction of AI capabilities in the VIVID WORKSTATION is expected to redefine innovation in pharmacy automation, leading to cost efficiencies for customers [4] - The company achieved a 27% year-over-year sales increase for VIVID products [6] - The DOTS MPS Platform was enhanced with single-use nanoparticles for baffled flasks, indicating ongoing innovation in bioprocessing solutions [6] Financial Overview - For Q3 2025, net revenues increased by $69,600 to $1,404,000, driven by the Torbal Division's performance [6] - Gross profit for Q3 2025 was $638,600, resulting in a gross margin of 45.5%, down from 51.0% in the prior year [9][20] - Operating expenses decreased by $84,800 to $2,160,900 for Q3 2025, reflecting cost reductions in Bioprocessing Systems Operations [10] Income Statement Highlights - The company reported a net income of $3,994,400 for Q3 2025, compared to a net loss of $1,180,100 in Q3 2024 [12][20] - Earnings per share for Q3 2025 were $0.34, a significant improvement from a loss of $(0.11) per share in the same period last year [12][21] - Total other income for Q3 2025 was $5,526,900, primarily due to a gain on the sale of the Genie Division [11][20]